Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.46 | €10.08 | 590.274% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €113.00 | €147.62 | 30.634% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 2 | 0 | €0.98 | €2.78 | 183.400% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.22 | €12.18 | 448.577% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.64 | €4.16 | 153.887% |
| Chemed Corp. | 5 | 0 | 1 | 0 | €535.00 | €588.14 | 9.933% |
| Radnet Inc. | 8 | 3 | 1 | 0 | €51.50 | €52.20 | 1.361% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.12 | €3.60 | 221.635% |
| Kezar Life Sciences | 5 | 0 | 1 | 0 | €0.75 | €18.56 | 2391.812% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €68.38 | €100.00 | 46.242% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €4.78 | €12.80 | 167.814% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.10 | €10.00 | 23.457% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €22.00 | €25.14 | 14.291% |
| Cerus Corp. | 4 | 0 | 2 | 0 | €1.61 | €3.26 | 102.129% |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.29 | €2.78 | 115.860% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.50 | €144.44 | 12.408% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €38.98 | €70.00 | 79.579% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.86 | €6.45 | 247.662% |
| Atossa Genetics Inc | 5 | 1 | 1 | 0 | €1.37 | €3.72 | 171.813% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |